NEXGEL, Inc. (NXGL) Q1 2026 Earnings Call Transcript
NEXGEL, Inc. (NXGL) Q4 2025 Earnings Call Transcript
NexGel (NASDAQ: NXGL - Get Free Report) is expected to be releasing its Q4 2025 results after the market closes on Monday, March 23rd. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $3.24 million for the quarter. Individuals can check the company's upcoming Q4 2025 earning summary page for the
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Adam R. Levy CEO | NASDAQ (CM) Exchange | 65344E107 CUSIP |
| US Country | 19 Employees | - Last Dividend | 2 Aug 1990 Last Split | 22 Dec 2021 IPO Date |
NEXGEL, Inc. is a company specializing in the manufacturing of high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Originally known as AquaMed Technologies, Inc., the company underwent a name change in November 2019. NEXGEL was incorporated in 2009 and has its headquarters in Langhorne, Pennsylvania. The innovative hydrogel technology that NEXGEL utilizes is catered to meet the needs of various industries, including wound care, medical diagnostics, transdermal drug delivery, and cosmetics, showcasing the company's versatility and commitment to advancing health and wellness solutions.
NEXGEL, Inc. offers a variety of products and services designed to leverage the benefits of hydrogel technology across several applications:
Their hydrogel products for wound care are designed to maintain a moist environment, which is conducive to healing. These products are known for their soothing effect, ability to promote faster healing, and the comfort they provide to users.
In the realm of medical diagnostics, NEXGEL’s hydrogels serve as conductive media, enhancing the performance of electrodes and sensors used in diagnostic procedures. Their superior conductivity and skin-friendly properties improve the quality and reliability of diagnostic tests.
The company's hydrogel products for transdermal drug delivery are engineered to facilitate the controlled release of medication through the skin. This method of delivery is advantageous for its ability to provide a steady dose over an extended period, improving patient compliance and comfort.
NEXGEL's hydrogel technology is also utilized in the cosmetics industry, where its products provide skin hydration and deliver active ingredients. Their cosmetic hydrogels are celebrated for their cooling effect, hydration properties, and ability to enhance the skin's absorption of beauty treatments.